The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate cancer in 2010, and another was approved in 2015 for melanoma. Since then, ...

a strategy aimed at the induction of CTLs directed against multiple and different tumor associated antigens may account for the results obtained. Moreover, using allogeneic dendritic cells as ...